Tatva Chintan Pharma Chem's quarterly market cap
increased
from Sep. 2023 (₹37,027 Mil) to Dec. 2023 (₹37,469 Mil) but then
declined
from Dec. 2023 (₹37,469 Mil) to Mar. 2024 (₹25,231 Mil).
Tatva Chintan Pharma Chem's annual market cap
declined
from Mar. 2022 (₹51,166 Mil) to Mar. 2023 (₹36,995 Mil) and
declined
from Mar. 2023 (₹36,995 Mil) to Mar. 2024 (₹25,231 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Tatva Chintan Pharma Chem's Enterprise Value for Today is ₹25,658 Mil.
Tatva Chintan Pharma Chem Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Tatva Chintan Pharma Chem's Market Cap
For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tatva Chintan Pharma Chem's Market Cap Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's Market Cap distribution charts can be found below:
* The bar in red indicates where Tatva Chintan Pharma Chem's Market Cap falls into.
Tatva Chintan Pharma Chem Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tatva Chintan Pharma Chem (NSE:TATVA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Tatva Chintan Pharma Chem Market Cap Related Terms
Thank you for viewing the detailed overview of Tatva Chintan Pharma Chem's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Tatva Chintan Pharma Chem (NSE:TATVA) Business Description
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:TATVA has been successfully added to your 